Search

everythinglearnresearchcommunity

for

Search:↓

Trichohyalin is a versatile protein involved in hair and skin structure.

The gummy supplement effectively promotes hair growth and is safe for women with hair thinning.

IVIG and dupilumab effectively improved symptoms in a child with Netherton syndrome.

DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.

Trichoscopy, a method of examining hair, can objectively measure how well botulinum toxin works for hair loss treatment.

Thyrotropin-Releasing Hormone helps heal wounds in frog and human skin.

5% topical minoxidil improves hair density and quality in monilethrix patients.

Beta-trace protein may help diagnose and predict treatment response in certain nerve disorders.

A new genetic mutation in the ODC1 gene causes developmental delay and other symptoms in a young girl.

New drug shows promise for better hair growth in baldness treatment.

Both steroids effectively promote hair growth for at least 9 months.

Trichohyalin in sheep hair follicles may help with structure and calcium binding.

The study concluded that a protein important for hair strength is regulated by certain molecular processes and is affected by growth phases.

Monilethrix is linked to the type II keratin gene on chromosome 12q13.

New mutations in KRT83 and KRT86 are linked to the hair disorder monilethrix.

Ciclosporin can cause excessive hair growth even with testosterone blockers.

Transgenic sheep embryos with a specific promoter were successfully created, but more research is needed for gene expression in hair follicles.

A gene mutation causes early keratinocyte maturation leading to hair loss in Olmsted syndrome.

Cellcurin serum significantly increased hair growth in people with androgenetic alopecia.

3D printing can greatly improve hair restoration and scalp treatments but faces challenges in clinical use.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

Injectable platelet-rich fibrin is better than platelet-rich plasma for promoting hair growth.

The oral supplement improved hair loss in patients with telogen effluvium.

Certain gene variations in the Vitamin D receptor may increase the risk of chronic hair loss.

New treatments for hair loss are being developed.

Nourkrin® with Marilex® may increase hair count by 35.7% in postpartum hair loss.

The compound (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile can stimulate hair growth and reduce oil production when applied topically.